Stay updated with breaking news from 37555810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stone Point Wealth LLC increased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 8.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 36,570 shares of the biopharmaceutical company’s stock after buying an additional 2,722 shares during the period. Gilead […]
Rovin Capital UT ADV lifted its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 83.9% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 5,708 shares of the biopharmaceutical company’s stock after purchasing an additional 2,604 shares during the quarter. Rovin Capital UT […]
Genesee Capital Advisors LLC cut its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 1.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 13,738 shares of the biopharmaceutical company’s stock after selling 162 shares during the quarter. Genesee Capital Advisors […]
SVB Wealth LLC lessened its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 1.7% in the 3rd quarter, Holdings Channel reports. The firm owned 74,964 shares of the biopharmaceutical company’s stock after selling 1,334 shares during the period. SVB Wealth LLC’s holdings in Gilead Sciences were worth $5,618,000 at the end […]
Private Asset Management Inc. cut its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 7.3% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 53,939 shares of the biopharmaceutical company’s stock after selling 4,225 shares during the period. Gilead […]